Cyclerion Therapeutics, Inc. (CYCN) Social Stream



Cyclerion Therapeutics, Inc. (CYCN): $2.69

0.41 (+17.98%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CYCN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#103 of 439

in industry

Featured Post From StockTwits About CYCN

$CYCN Alzheimer results from Ph2a if study begins by mid July and takes 12 weeks it will be done by Sept end. Give them few months to analyze the data latest by January we will have Alzheimer data as well. Run up to Alzhiemer data as well as MELAS data which they have announced will be in q4. Should be 10 any moment
james2609, published August 10, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!